Cardioneuroablation for Treating Vasovagal Syncope: Current Status and Future Directions
Syncope is defined by transient and spontaneous loss of consciousness with rapid recovery. Vasovagal syncope (VVS) is the most common form of syncope and is strongly associated with hypervagotonia. There is, however, a lack of effective therapies for VVS. Cardioneuroablation (CNA) is an emerging and...
Main Authors: | Le Li, Sunny Po, Yan Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2023-06-01
|
Series: | Arrhythmia & Electrophysiology Review |
Online Access: | https://www.aerjournal.com/articleindex/aer.2023.02 |
Similar Items
-
Cardioneuroablation: Present status as a tenable therapy for vasovagal syncope
by: Richard Sutton, et al.
Published: (2019-01-01) -
Cardioneuroablation for Drug Refractory Vasovagal Syncope After COVID-19 Infection
by: Stefanos Zafeiropoulos, MD, PhD, et al.
Published: (2024-07-01) -
Cardioneuroablation as a strategy to prevent pacemaker implantation in young patients with vasovagal syncope
by: Jacqueline Joza, et al.
Published: (2024-04-01) -
Cardioneuroablation for recurrent vasovagal syncope and functional sinus bradycardia: a case series
by: T. Shalganov, et al.
Published: (2023-12-01) -
Cardioneuroablation for the Treatment of Vasovagal Syncope Induced by Chili Pepper Stimulation: A Case Report
by: Huang R, et al.
Published: (2024-11-01)